PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90

Reported: July 17, 2019 Initiated: June 14, 2019 #D-1465-2019

Product Description

Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90

Reason for Recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Details

Units Affected
32,835 bottles (2,955,150 tablets)
Distribution
US Nationwide One (1) US government account. No foreign accounts.
Location
Camarillo, CA

Frequently Asked Questions

What product was recalled?
Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90. Recalled by Golden State Medical Supply Inc.. Units affected: 32,835 bottles (2,955,150 tablets).
Why was this product recalled?
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2019. Severity: Moderate. Recall number: D-1465-2019.